Next-Generation Luminescence-Based Radiation Therapy System

Publication ID: 24-11857806_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Luminescence-Based Radiation Therapy System,” Published Technical Disclosure No. 24-11857806_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857806_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,806.

Summary of the Inventive Concept

A real-time radiation therapy monitoring and personalized treatment system utilizing luminescence-based dosimetry and machine learning algorithms to optimize treatment efficacy and patient outcomes.

Background and Problem Solved

Conventional radiation therapy methods, as described in the original patent, often lack real-time monitoring capabilities, leading to potential under- or over-dosage. The new inventive concept addresses this limitation by integrating luminescence-based dosimetry and machine learning algorithms to provide personalized, adaptive radiation therapy plans.

Detailed Description of the Inventive Concept

The next-generation system comprises a wearable device incorporating an OSL material, which detects luminescence emissions in response to ion beam therapy and transmits corresponding data to a remote server for analysis and feedback. The system also includes a machine learning module trained on a dataset of luminescence-based radiation therapy outcomes, which predicts optimal radiation therapy plans for individual patients based on their unique characteristics and treatment goals. Furthermore, the system utilizes 3D modeling of patient tumors using luminescence-based imaging to adapt ion beam therapy plans and optimize treatment efficacy.

Novelty and Inventive Step

The new claims introduce a paradigm shift in radiation therapy by integrating real-time luminescence-based dosimetry, machine learning algorithms, and personalized treatment planning. This inventive step enables adaptive radiation therapy, which was not possible with the original patent's methodology.

Alternative Embodiments and Variations

Alternative embodiments may include implantable OSL sensors, flexible substrate-based wearable devices, or cloud-based machine learning modules. Variations may involve different luminescence materials, radiation therapy modalities, or data analysis algorithms.

Potential Commercial Applications and Market

The next-generation luminescence-based radiation therapy system has significant commercial potential in the healthcare industry, particularly in cancer treatment centers and hospitals. The system's ability to provide real-time monitoring and personalized treatment plans can improve patient outcomes, reduce treatment costs, and enhance the overall quality of care.

Original Patent Information

Patent NumberUS 11,857,806
TitleLuminescence-based method for precise delivery of ion beam therapy
Assignee(s)United States of America as represented by the Secretary of the Navy